Inventor · disambiguated record
Joachim Rehse
Also filed as: REHSE JOACHIM
12 granted patents·4 pending applications·182 citations·filing 1994–2019
92Inventor score
Files withADVERIO PHARMA GMBH3BAYER HEALTHCARE LLC3BAYER IP GMBH2MAIS FRANZ-JOSEF2AICURIS GMBH & CO KG1
Top patents by PatentIndex Score
16 records- 0193US8492544B2Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}Methylcarbamate and its purification for use as pharmaceutically active compoundMAIS FRANZ-JOSEF·Filed 2010·Granted Jul 23, 2013·27 cites·2 claims
- 0293US7351823B2Preparation processBAYER HEALTHCARE AG·Filed 2005·Granted Apr 1, 2008·54 cites·14 claims
- 0392US8853398B2Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compoundBAYER IP GMBH·Filed 2013·Granted Oct 7, 2014·15 cites·4 claims
- 0491US8501945B2Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate and its purification for use as pharmaceutically active compoundMAIS FRANZ-JOSEF·Filed 2010·Granted Aug 6, 2013·23 cites·2 claims
- 0589US10351562B2Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compoundADVERIO PHARMA GMBH·Filed 2018·Granted Jul 16, 2019·6 cites·9 claims
- 0688US5502199AProcess for preparing sodium 3R,5S-(+)-erythro-(E)-7- 4-(4-fluorophenyl)-2,6-diisopropyl-5-methoxymethyl-pyrid-3-yl!-3,5-dihydroxy-hept-6-enoateBAYER AG·Filed 1994·Granted Mar 26, 1996·43 cites·8 claims
- 0780US9340535B2N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrateAICURIS GMBH & CO KG·Filed 2012·Granted May 17, 2016·5 cites·25 claims
- 0878US10030014B2Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compoundADVERIO PHARMA GMBH·Filed 2014·Granted Jul 24, 2018·2 cites·5 claims
- 0977US8748622B2Process for the preparation of 4-{4[({[4-chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorophenoxy}-N-methylpyridine-2-carboxamide, its salts and monohydrateSTIEHL JUERGEN·Filed 2011·Granted Jun 10, 2014·5 cites·11 claims
- 1076US9458107B2Process for the preparation of 4-{4-[({[4 chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorphenoxy-N-ethylpyridie-carboxamide, its salts and monohydrateBAYER HEALTHCARE LLC·Filed 2014·Granted Oct 4, 2016·2 cites·30 claims
- 1169US10570130B2Process for preparing methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compoundADVERIO PHARMA GMBH·Filed 2019·Granted Feb 25, 2020·0 cites·2 claims
- 1266US10822305B2Process for the preparation of 4-(4-amino-3-fluorophenoxy)-N-methylpyyridine-2-carboxamideBAYER HEALTHCARE LLC·Filed 2019·Granted Nov 3, 2020·0 cites·25 claims
- 1357US2017334857A1Method of Purifying and using 4-chloro-n-methy1-2-pyridinecarboxamideBAYER HEALTHCARE LLC·Filed 2017·Application pending·0 cites
- 1455US2017057918A1Process for the preparation of 4-carbonyl)amino]-3-fluorophenoxy}-n-ethylpyridine-2-carboxamide, its salts and monohydrateBAYER IP GMBH·Filed 2016·Application pending·0 cites
- 1541US2003232989A1Process for the preparation of specific aromatic aldehydesFiled 2003·Application pending·0 cites
- 1631US2012220762A1Method for the manufacture of 2-fluoro-ara-adenineBERWE MATHIAS·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →